These 2 Stocks Just Broke Out — and They Could Go Higher, Say Analysts
Past performance may not guarantee future results, but it can still provide valuable clues. When a stock suddenly breaks higher on unusually strong...
Replimune Group Inc. (REPL)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 1,774 | $396,972 | +242% | 0.12% | |
| 2. | 20,600 | $228,042 | 0% | ||
| 3. | 1,280 | $115,200 | +4% | 0.03% | |
| 4. | Winton Capital Management David Harding | 10,400 | $115,128 | 0% | |
| 5. | Walleye Capital Will England | 2,729 | $30,210 | -97% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $13.61 | 1,100,000 | $14,971,000.00 | 1,100,000 | 2019-11-18 | Filing | |
| $13.61 | 220,000 | $2,994,200.00 | 5,328,939 | 2019-11-18 | Filing | |
| $15.00 | 133,333 | $1,999,995.00 | 4,721,449 | 2018-07-24 | Filing | |
| $15.00 | 6,667 | $100,005.00 | 6,667 | 2018-07-24 | Filing | |
| $15.00 | 133,333 | $1,999,995.00 | 4,721,449 | 2018-07-24 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $9.24 | 12,000 | $110,880.00 | 180,962 | 2026-06-01 | Filing | |
| $5.08 | 14,023 | $71,236.84 | 235,662 | 2026-05-18 | Filing | |
| $5.08 | 7,894 | $40,101.52 | 107,057 | 2026-05-18 | Filing | |
| $5.08 | 8,626 | $43,820.08 | 192,962 | 2026-05-18 | Filing | |
| $5.08 | 17,657 | $89,697.56 | 1,412,414 | 2026-05-18 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 8,958,535 | $99,170,982 | 0% | |
| 2. | 4,440,144 | $49,152,394 | 0% | |
| 3. | 2,120,000 | $23,744,000 | 0.18% | |
| 4. | 300,000 | $3,321,000 | 0% | |
| 5. | 235,405 | $2,605,936 | 0% |
News See All
Why Is Replimune (REPL) Stock Up Today?
Replimune stock rallied on Friday thanks to an FDA update that acted as a catalyst for analyst upgrades.
Why is Biotech Stock Replimune (REPL) Soaring Over 120% Today?
Shares in biotechnology company Replimune ($REPL) soared over 120% in pre-market trading today after U.S. regulators gave the thumbs up to its skin...
Jefferies Sees Reduced Visibility for Replimune Group, Inc. (REPL) Following FDA Decision
TheFly reported on April 13 that Jefferies cut its rating on REPL from Buy to Hold and reduced its price target sharply to $2 from $13.
10 Best Biotech Stocks Under $10 to Buy
According to Eli Casdin, CEO of Casdin Capital, biotech is currently experiencing a momentary stop despite being in one of the best economic environments in years.
Replimune Group (REPL) Nosedives 39% as FDA Approval for Melanoma Treatment 'Uncertain'
Replimune extended losses to a second consecutive day on Thursday, slashing 39.40 percent to close at $3.46 apiece after failing to clear regulatory challenges for its treatment candidate for melanoma...
Replimune Group, Inc. (NASDAQ:REPL) Q4 2025 Earnings Call Transcript
Operator: Good morning and welcome to the Replimune Fiscal Year Fourth Quarter 2025 Financial Results and Corporate Update Conference Call. Currently, all participants are in listen-only mode.
12 Best Medical Stocks to Buy Under $10
In this article, we will take a look at the 12 best medical stocks to buy under $10.
15 Small-Cap Stocks with High Potential
In this article, we will take a look at the 15 small-cap stocks with high potential.
12 Stocks with Biggest Upside Potential According to Analysts
In this article, we will take a look at the 12 stocks with biggest upside potential according to analysts.